Skip to main content

. 1990 May;61(5):765–766. doi: 10.1038/bjc.1990.171

Vincristine, adriamycin and high dose steroids in myeloma complicated by renal failure.

R G Aitchison ¹, I A Reilly ¹, A G Morgan ¹, N H Russell ¹

PMCID: PMC1971600 PMID: 2337514

765

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Barlogie B., Smith L., Alexanian R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med. 1984 May 24;310(21):1353–1356. doi: 10.1056/NEJM198405243102104. [DOI] [PubMed] [Google Scholar]
Cavo M., Baccarani M., Galieni P., Gobbi M., Tura S. Renal failure in multiple myeloma. A study of the presenting findings, response to treatment and prognosis in 26 patients. Nouv Rev Fr Hematol. 1986;28(3):147–152. [PubMed] [Google Scholar]
Forgeson G. V., Selby P., Lakhani S., Zulian G., Viner C., Maitland J., McElwain T. J. Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients. Br J Cancer. 1988 Oct;58(4):469–473. doi: 10.1038/bjc.1988.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rota S., Mougenot B., Baudouin B., De Meyer-Brasseur M., Lemaitre V., Michel C., Mignon F., Rondeau E., Vanhille P., Verroust P. Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients. Medicine (Baltimore) 1987 Mar;66(2):126–137. doi: 10.1097/00005792-198703000-00004. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES